SCHEMBL9954640

SCHEMBL9954640

O=C(Nc1ccccc1)Nc1ccc(Br)cn1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.73
NPC1 O15118 9/20 0.73
ALDH1A1 P00352 3/20 0.68
MAPT P10636 3/20 0.64
MAOA P21397 1/20 0.64
MAOB P27338 1/20 0.64
SMN1; SMN2 Q16637 5/20 0.61
ADORA3 P0DMS8 1/20 0.61
PIM1 P11309 1/20 0.61
ADORA2A P29274 1/20 0.61
ADORA2B P29275 1/20 0.61
ADORA1 P30542 1/20 0.61
FLT3 P36888 1/20 0.61
PIM3 Q86V86 1/20 0.61
AURKB Q96GD4 1/20 0.61
LMNA P02545 2/20 0.58
NPSR1 Q6W5P4 1/20 0.58
KDM4E B2RXH2 1/20 0.58
TSHR P16473 2/20 0.55
KMT2A Q03164 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9954182 0.86 RAB9A (0.71) RAB9ANPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL9954835 0.85 TSHR (0.68) RAB9ANPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL31241075 0.84 RAB9A (0.74) RAB9ANPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL31241036 0.83 RAB9A (0.71) RAB9ANPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL31241072 0.81 RAB9A (1.00) RAB9ANPC1MAPTSMN1; SMN2LMNA
SCHEMBL1018755 0.81 HCAR3 (0.69) RAB9ANPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL27578720 0.81 L3MBTL1 (0.77) RAB9ANPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL27581139 0.81 RAB9A (0.73) RAB9ANPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL28513546 0.81 RAB9A (0.62) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL3461453 0.81 RAB9A (0.62) RAB9ANPC1MAPTSMN1; SMN2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118812505-A PI5P4K gamma inhibitor compound, pharmaceutical composition, and preparation method and application thereof 贵州医科大学 2024-10-22 CN disclosed
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed